Photo Credit: Courtesy Apple
During an Apple Inc. quarterly earning call, CEO Tim Cook announced the financial results for its fiscal 2015 fourth quarter, which ended Sept. 26th. The company seems to be quite swell, following the debut of its new iPhone 6S and iPhone 6s Plus.
According to the company, there was a quarterly revenue $51.5 billion and quarterly net profit of $11.1 billion, or $1.96 per diluted share. It’s earnings were way ahead of expectations, thanks to the new iPhones, the expanded availability of watches and all-time record sales or Mac.
“Fiscal 2015 was Apple’s most successful year ever, with revenue growing 28 percent to nearly $234 billion. This continued success is the result of our commitment to making the best, most innovative products on earth, and it’s a testament to the tremendous execution by our teams,” Cook said. “We are heading into the holidays with our strongest product lineup yet, including iPhone 6s and iPhone 6s Plus, Apple Watch with an expanded lineup of cases and bands, the new iPad Pro and the all-new Apple TV which begins shipping this week.”
Just last month, the company announced record iPhone 6s and iPhone 6s Plus sales. The company sold more than 13 million new phones in just three days after the launch. Following the announcement of fiscal fourth quarter endings, Apple said it sold 48.04 million iPhones, surpassing sales of 39.27 million units in 2014.
In addition to ending its fiscal 2015 fourth quarter on such a good note, the company has launched new clean energy programs in China as well as a new tool called ResearchKit, which is enabling new research studies on autism, epilepsy and melanoma.
The clean energy programs will avoid over 20 million metric tons of greenhouse gas pollution in the country between now and 2020, equivalent to taking nearly 4 million passenger vehicles off the road for one year. The new tool ResearchKit turns the iPhone into a powerful tool for medical research by helping doctors, scientists and other researchers gather data more frequently and more accurately from participants using iPhone apps. Those who participate in studies to help autism, epilepsy and melanoma will be able to review an interactive informed consent process, easily complete active tasks or submit survey responses, and choose how their health data is shared with researchers, making studies easier than ever.